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Cancer continues to represent the largest cause of mortality in the 
world and claims over 6 million lives each year. An extremely 
promising strategy for cancer prevention today is chemoprevention, 
which is defined as the use of synthetic or natural agents (alone or in 
combination) to block the development of cancer in human beings. 
Plants, vegetables, herbs and spices used in folk and traditional 
medicine have been accepted currently as one of the main sources of 
cancer chemopreventive drug discovery. Hydroalcoholic extracts of 
Terminalia chebula, Terminalia belerica, Emblica officinalis, 
Caesalpinia crista, Cajanus cajan, and Tinospora cordifolia are found 
to be variably and selectively cytotoxic to normal and EAC cells. 
Hydroalcoholic extracts of Terminalia chebula, Terminalia belerica, 
Emblica officinalis, Caesalpinia crista, Cajanus cajan, and Tinospora 
cordifolia which have been found to be possible natural antioxidant 
are evaluated for their selective cytotoxic effect on murine tumor cell 
Ehrlich’s Ascites Carcinoma (EAC) and normal spleenocyte cell. The 
extracts were subjected to cytotoxicity test by the tetrazolium cell 
proliferation reagent (WST-1) assay in vitro. The results showed that 
the plant extracts were invariably non toxic for the normal 
spleenocyte cell, whereas they showed toxicity for EAC cells in 
different degree. The cell cycle analysis for the EAC cells treated with 
the extracts of the aforesaid plants showed a variable, yet dose-
dependent increasing percentage of apoptosis. The results signify that 
the plants which have antioxidant property may function as cytotoxic 
agent for cancer cell. 
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Introduction 
Over the past few years, cancer has remained a 
major cause of death and the number of 
individuals living with cancer is continuing to 
expand. Hence, a major portion of the current 
pharmacological research is devoted to anticancer 
drug design customized to fit new molecular 
targets [1]. Chemotherapy is a major treatment 
modality for cancer and some plants have 
provided active principles, which are used to 
control the advanced stages of malignancies in 
clinical settings [2,3]. However, most of these 
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chemotherapeutic agents exhibit severe normal 
toxicity, and cause undesirable side effects. Many 
of the potent drugs are highly expensive, 
mutagenic, carcinogenic and teratogenic. 
Therefore, a need is felt to find alternative drugs, 
which are highly effective at non-toxic doses, 
inexpensive and accessible to common man. This 
can be achieved by screening plant products with 
antioxidant property, which may be effective at 
non-toxic dose levels, since antioxidants are 
compounds that protect cells from free-radical 
induced degenerative diseases like cancer. Due to 
the enormous propensity of plants to act as 
natural antioxidants by scavenging of reactive 
oxygen species (ROS), through synthesis of a 
variety of structurally diverse bioactive 
compounds, the plant kingdom is a potential 
source of chemical constituents with antitumor 
and cytotoxic activities [4-6].  
Experimental tumors have great importance in 
modeling, and Ehrlich ascites carcinoma (EAC) 
is one of the commonest tumors. EAC is referred 
to as an undifferentiated carcinoma and is 
originally hyperdiploid, has high transplantable 
capability, rapid proliferation, shorter life span, 
100% malignancy and also does not have tumor-
specific transplantation antigen. EAC resembles 
human tumors which are the most sensitive to 
chemotherapy due to the fact that they are 
undifferentiated and that they have a rapid growth 
rate. The ideal drug being ineffective or 
minimally effective for normal cells have been 
focused on, and at this point, the usage of natural 
sources as an alternative cancer therapy is 
thought to have a great value for cancer control. 
Of the six plants studied here, Terminalia 
chebula Retz. has been reported for its anticancer 
activity [7] and along with two other Myrobalans, 
viz., Terminalia belerica Roxb. and Emblica 
officinalis Gaertn. has produced an Ayurvedic 
polyherbal formula, Triphala which has been 
established as potent anticancer agent [8,9] for 
quite some time. These plants have already been 
reported to have antioxidant property [10]. The 
other plants used in the study, viz., Caesalpinia 
crista Linn. and Tinospora cordifolia (Thunb.) 
Miers have already been reported as a natural 
antioxidant [11,12], along with antineoplastic 
effect of the methanol extract of the former and 
dichloromethane extract of the latter plant on 
EAC bearing mice [13,14]. Lastly, antioxidative 
and anticancer properties of Cajanus cajan (L.) 
Millsp. has already been reported [15-17]. 
However, no earlier study has been done 
regarding the cytotoxic effect of the 
hydroalcoholic extract of the aforementioned 
plants on EAC cell in vitro, thus initiating the 
effort for the study. 
Materials and Methods 
Collection & Authenticity of medicinal plants 
The plant materials were collected from Bankura 
district of West Bengal, India and the genus and 
species of the medicinal plants are authenticated 
through the Central Research Institute 
(Ayurveda), Kolkata, India, where specimens for 
each plant were deposited. A list of the specimen 




Name of the plant CRI (Ayurveda) 
specimen No. 
1 Terminalia chebula CRHS 113/08 
2 Terminalia belerica CRHS 114/08 
3 Emblica officinalis CRHS 115/08 
4 Caesalpinia crista CRHS 121/08 
5 Cajanus cajan CRHS 119/08 
 
Preparation of Plant Extract 
The powder (100 g) of the dried fruits of T. 
chebula, T. belerica and E. officinalis, leaves of 
C. crista and C. cajan or stem of T. cordifolia 
was stirred using a magnetic stirrer with 500 ml 
mixture of ethanol:water (6:4) (hydro-alcoholic 
extract) for 15 hours; then the mixture was 
centrifuged at 2850 x g and the supernatant 
decanted. The process was repeated again with 
the precipitated pellet. The supernatants were 
collected, concentrated in a rotary evaporator at 
room temperature and freeze dried in a 




lyophilizer. The dried extract was stored at -20°C 
until use. 
Animals 
The Animal Ethical Clearance Committee of the 
Institute (Registration number: 95/1999/ 
CPCSEA) approved the use of adult male Swiss 
Albino mice, weighing 20-25 gm for 
experimentation. The animals were obtained from 
Chittaranjan National Cancer Institute (CNCI), 
Kolkata, India. They were housed in standard 
environmental conditions of temperature (25 ± 
2°C), humidity (60 ± 5%) and under light and 
dark cycles of 12-h.The mice were fed standard 
laboratory diet and were given sterilized water ad 
libitum. 
Isolation of Cancer cells (EAC) 
The transplantable cancer cell namely Ehrlich’s 
Ascites Carcinoma (EAC) cells were used in the 
present study. The EAC cells were maintained in 
vivo in Swiss albino mice, by interperitoneal (ip) 
transplantation of 2 x 106 cells /mouse after every 
10 days. EAC cells 9 days old were used for the 
experiment. These tumors in the ascites form are 
fast growing and kill the host animals within the 
period of three-four weeks approximately after 
tumor transplantation with 2 x 106 cells. The 
tumor uptake by the host was manifested by a 
very high initial growth rate followed by 
exponential growth up to a period of 10th day post 
transplantation (log phase) followed by gradual 
decline in this growth rate with progressive 
accumulation of ascites fluid (lag phase). By the 
21st day post transplantation, the tumor volume 
reaches its maximum. 
The mice were killed by cervical dislocation 
(acceptable method of euthanasia), dissected and 
the ascitic fluid was collected from the peritoneal 
cavity. The volume was measured by taking it in 
a graduated centrifuge tube and packed cell 
volume was determined by centrifuging at 1000 
rpm for 5 min. It was then resuspended in excess 
RPMI-1640 medium (with 10% HI FBS) and 
taken in sterile Petri dishes and incubated in a 
CO2 incubator (37°C; 5% CO2) for 1 h. The cells 
of macrophage lineage adhered to the bottom of 
the Petri dishes. The non-adherent population was 
aspirated out gently and washed repeatedly with 
PBS. The cells were centrifuged at 3000 rpm for 
5 min, resuspended in medium and counted in a 
haemocytometer. 
Isolation of Spleenocyte 
Spleens from normal healthy mice were dissected 
after sacrifice of the mice and washed twice with 
sterilized PBS. The spleen was then taken in a 
Petri dish containing RPMI-1640 medium (with 
10% HI FBS) and incubated in a CO2 incubator 
(37°C; 5% CO2) for 1 h. The non-adherent 
spleenocyte population was aspirated out gently, 
centrifuged at 3000 rpm for 5 min, resuspended 
in medium and counted in a haemocytometer. 
Cytotoxicity and Cell Viability 
For the estimation of the cytotoxic activities of 
the plant extracts, a colorimetric assay was 
employed for quantification of cell proliferation, 
cell viability, and cytotoxicity using a kit (Cell 
Proliferation Reagent WST-1) from Roche 
Diagnostics GmbH. The cytotoxicity of the 
various concentrations of hydroalcoholic crude of 
the different plants were evaluated in both EAC 
and Spleenocyte cells, where separate 
experiments were set up for each cell line. 
Briefly, 1 × 104 viable cells from each cell line 
were seeded into a 96-well flat bottomed plate 
with requisite amount of RPMI-1640 medium. 
Thereafter, the cells were treated with various 
concentrations of each plant extract (in 
triplicates) and were left undisturbed and allowed 
to grow for 16 h. Then, 10 μl/well Cell 
Proliferation Reagent WST-1 was added and 
again incubated for one and a half hour. It was 
shaken thoroughly for 1 min on a shaker. The 
absorbance of the samples was measured against 
a background control as blank using a microplate 
(ELISA) reader at 450 nm. 
Anticancer activity based on quantification of 
apoptotic cell by flowcytometry 




For the determination of cell cycle phase 
distribution, around 1.5-2 × 106 cells were 
cultured in several 24-well plates containing 
RPMI-1640 medium (with 10% HI FBS) and 
treated with various concentrations of each plant 
extract (in triplicates) and were left undisturbed 
and allowed to grow for 16 h in a CO2 incubator 
(37°C; 5% CO2). Post treatment, the cells were 
centrifuged to discard any medium, fixed with 
chilled methanol and diluted with sterilized PBS. 
After dilution, Triton X-100 and RNAse A were 
added to permeate the cell wall and digest the 
RNA during incubation for 3 hrs at 37°C. 
Nuclear DNA of EAC cells was labeled with 
ethidium bromide and phase distribution was 
determined on FACS, fluorescence detector 
equipped with 488 nm argon laser light source 
and 623 nm band pass filter (linear scale) using 
CellQuest software (Becton Dickinson). A total 
of 10,000 events were acquired and analysis of 
flowcytometric data was performed using ModFit 
software. A histogram of DNA content (x-axis, 
red fluorescence) versus counts (y-axis) has been 
displayed. 
Statistical analysis 
All data are reported as the mean ± SD of six 
measurements. Statistical analysis was performed 
using KyPlot version 2.0 beta 15 (32 bit). The 
IC50 values were calculated using the formula Y 
= 100*A1/(X + A1) where A1 = IC50, Y = 
response (Y = 100% when X = 0), X = inhibitory 
concentration. The IC50 values were compared by 
paired t-Test. The results with a value of p < 0.05 
were considered significant. 
Results & Discussion 
Cancer is a disease of misguided cells that have 
high potential of excess proliferation without 
apparent relation to the physiological demand of 
the process. It is the second largest cause of death 
in the world. Of all the available anticancer drugs 
during 1940 – 2002, 40% were natural products 
per se or natural product derived, with another 
8% being natural product mimics [18]. The 
greatest recent impact of plant derived drugs is 
observed in the area of antitumor research, where 
compounds such as taxol, vinblastine, vincristine, 
and camptothecin have dramatically improved the 
effectiveness of chemotherapy against some of 
the dreaded cancers [19]. Hence, there is a great 
potential for the development of anticancer drugs 
from the essentially untapped reservoir of the 
plant kingdom. A large number of plants 
possessing anticancer properties have been 
documented [4,20-22]. 
Cytotoxicity and Cell Viability 
Biological activity of any plant is most certainly 
depends on its cytotoxic property. For that 
purpose, the cytotoxicity effect of the 
hydroalcoholic extracts of the plants were studied 
on both normal cells (spleenocyte) and cancer 
cell (EAC). 
The results (Figure 1) showed that all the 6 plant 
extracts showed no or very low cytotoxic activity 
against healthy normal spleenocyte cell lines 
tested. The low cytotoxic potential of the extracts 
is of great significance for their traditional use in 
the treatment of various disorders along with 
cancer. 
Moderate or highly selective cytotoxic activity 
was observed for all the plant extracts against 
EAC cell lines (Figure 2) as is also evident from 
their IC50 values (Table 1). The extracts of 
Terminalia belerica and Emblica officinalis 
displayed moderate cytotoxicity (IC50 564.06 ± 
77.03 μg/ml and 542.53 ± 44.51 μg/ml, 
respectively, whereas the hydroalcoholic extracts 
from Terminalia chebula fruits and Tinospora 
cordifolia bark showed significantly lower IC50 
values of 344.06 ± 22.09 μg/ml and 306.34 ± 
44.75 μg/ml, respectively. However, the extracts 
from Caesalpinia crista and Cajanus cajan 
leaves showed the highest cytotoxicity (IC50 
188.42 ± 18.74 μg/ml and 168.42 ± 29.49 μg/ml) 
against EAc cell lines among all extracts tested in 
this study. The cytotoxic activities of the 
hydroalcoholic extracts of the plants as 
summarized in Table 1, is worth noting since the 
IC50 values for some plants, viz., Terminalia 
belerica and Emblica officinalis, while somewhat 
high, still point subtly towards selective activity.  








Figure 1: Cytotoxicity for normal spleenocytes 
Effect of the plant extracts on normal spleenocyte cells. The results were expressed as mean ± S.D. (n=6). 
All the data were found to be highly significant with respect to control. 
 
 
Figure 2: Cytotoxicity for Ehrlich’s Ascites Carcinoma 
Effect of the plant extracts on normal spleenocyte cells. (a) The extracts of Terminalia chebula and Caesalpinia 
crista showed significant toxicity at lower levels (0-80 μg/ml), whereas (b) a higher concentration range was to be 
observed for the extracts of Cajanus cajan, Terminalia belerica, Emblica officinalis and Tinospora cordifolia (0-200 
μg/ml). All data are expressed as mean ± S.D. (n=6). *p < 0.05, **p < 0.01 and ***p < 0.001 vs. 0 µg/ml. 
 




Table 1: IC50 values for the cytotoxic capacities of hydroalcoholic extracts of the studied plants 
 
Serial No. Name of the plant 
IC50 values (in μg/ml) for the cytotoxic effect on EAC 
cell 
1. Terminalia chebula 344.06 ± 22.09*** 
2. Caesalpinia crista 188.42 ± 18.74*** 
3. Cajanus cajan 168.42 ± 29.49** 
4. Terminalia belerica 564.06 ± 77.03NS 
5. Emblica officinalis 542.53 ± 44.51** 
6. Tinospora cordifolia 306.34 ± 44.75* 
IC50 values of the extracts are represented as mean ± SD (n=6). * p< 0.05; **


































Figure 3: Cell cycle analysis for EAC treated with plant extracts 
Induction of apoptosis by the plant extracts on Ehrlich’s Ascites Carcinoma (EAC) cells. The histogram 
analysis of the cell cycle for each plant has been depicted in different colors. The subgroupings of each 
picture signifies (a) cell cycle for the EAC treated with no dose and (b) highest dose of the mentioned plant 
extracts. Areas marked in each histogram signifies: M1 – G0 phase; M2 – G1phase; M3 – S phase; and M4 

















Figure 4: Comparison of apoptosis in EAC cells among various medicinal plants 
Induction of apoptosis by the plant extracts on Ehrlich’s Ascites Carcinoma (EAC) cells. All data are 




These “high” values are likely due to very low 
concentrations of compounds of interest, which 
would be considerably enriched upon bioactivity-
guided fractionation. 
Anticancer activity based on induction of 
apoptotic cell: 
Since anticancer activity of any compound should 
induce apoptosis of cancer cell, our in vitro 
studies have shown that the plant extracts were 
effective in imparting growth inhibition, cell 
cycle deregulation and apoptosis in EAC cells. 
Apoptotic cell death was measured as the percent 
of cells with hypodiploid DNA. 
The histogram analyses of the interphase cycle of 
EAC cells treated with plant extracts as shown in 
Figure 3 indicate that the hydroalcoholic extracts 
of three plants, viz., Terminalia belerica, Cajanus 
cajan and Tinospora cordifolia selectively 
induced apoptosis of cancerous EAC cell in a 
dose dependent manner. The variation of 
apoptosis of EAC cells as induced by the plant 
extracts is furthermore quantified to get a better 
picture of the comparative activity of plant 
extracts as has been shown in the Figure 4. The 
figure as can be found undoubtedly corroborates 
with the histogram analysis of the cell cycle for 
the plant extract treated EAC cells. The 
qualitative indication that the plant extracts of 
Terminalia belerica, Cajanus cajan and 
Tinospora cordifolia are more effective than the 
other three has been quantitatively confirmed in 
this comparison of percentage of apoptosis. 





In the Ayurvedic system of treatment, dry powder 
or crude extracts of plants are used to treat 
various disorders including cancer. Many such 
compounds are known to possess potent 
antitumor properties [23]. The observed effect is 
attributed to not only a single compound but also 
the other components present in the crude 
extract/s. The rationale for this type of treatment 
is that the toxicity of an active component may be 
counteracted by another component, which may 
not have the desired therapeutic property. 
This study supports the traditional uses of 
Caesalpinia crista and the reported cytotoxic 
activities of Terminalia chebula, Cajanus cajan, 
and Tinospora cordifolia. Some of the plant 
extracts, such as Terminalia belerica and Emblica 
officinalis exerted selective cytotoxic activity, but 
neither cytotoxic activity had been reported 
previously. This study provides an important 
basis for further investigation into the isolation, 
characterisation and mechanism of cytotoxic 
compounds from some of the screened 
Bangladeshi medicinal plants. Thus, these plants 
could be used as a source for new lead structures 
in drug design to combat cancer. 
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